Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs 8x8 Inc (EGHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs 8x8 Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B), while 8x8 Inc trades at $2.17 (market cap $316.17M). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 25.4× 8x8 Inc's market cap. Which is the better fit depends on your goals.
| BIO | EGHT | |
|---|---|---|
Market Cap | $8.02B | $316.17M |
Sector | Health | Technology |
52-Week High | $339.75 | $2.76 |
52-Week Low | $241.71 | $1.59 |
Enterprise Value | $7.84B | $593.85M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →
